Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$55.60−2.41 (-4.15%)
Close on Nov 18, 2026Market cap $2.72BP/E –Yield –
Celcuity operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Celcuity's operating income for the twelve months ending Jun 30, 2026 was -$208.68M. For fiscal 2025 it was -$172.19M. The highest annual figure on record is -$3.33M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$172.19M | – |
| FY2024 | Dec 31, 2024 | -$113.27M | – |
| FY2023 | Dec 31, 2023 | -$66.23M | – |
| FY2022 | Dec 31, 2022 | -$39.39M | – |
| FY2021 | Dec 31, 2021 | -$28.36M | – |
| FY2020 | Dec 31, 2020 | -$9.56M | – |
| FY2019 | Dec 31, 2019 | -$7.81M | – |
| FY2018 | Dec 31, 2018 | -$7.93M | – |
| FY2017 | Dec 31, 2017 | -$5.95M | – |
| FY2016 | Dec 31, 2016 | -$3.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$66.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$50.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$49.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$42.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$44.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$36.13M | – |
| Q4 FY2024 | Dec 31, 2024 | -$36.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$30.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$24.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.49M | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.55M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.64M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.32M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.79M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.31M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.90M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.97M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.95M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.93M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.08M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.82M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.53M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.61M | – |
| Q1 FY2017 | Mar 31, 2017 | -$993.91K | – |
| Q4 FY2016 | Dec 31, 2016 | -$907.41K | – |
| Q3 FY2016 | Sep 30, 2016 | -$877.54K | – |
See a number that looks wrong?